Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Fresenius Medical Care AG & Co. KGaA logo
FME.DE
Fresenius Medical Care AG & Co. KGaA
13:12:16
40.54 €
0.0000 (%0.00)
Previous Close: 41.26
Day Low₺40.2
Day High₺41.12
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

FME.DE: Fresenius Medical Care AG & Co. KGaA Financials

Fresenius Medical Care AG & Co. KGaA Income Statement

Total revenue
Net income
Gross margin TTM
25.62%
Operating margin TTM
9.36%
Net profit margin TTM
4.98%
Return on investment TTM
7.35%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue19,628,000,00019,335,909,00019,453,617,00019,398,000,000
Operating income1,838,000,0001,392,395,0001,369,438,0001,537,946,000
Net income978,000,000537,913,000498,997,000673,405,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue19,628,000,00019,335,909,00019,453,617,00019,398,000,000
Cost of revenue14,599,000,00014,579,257,00014,528,612,00014,504,328,000
Gross profit5,029,000,0004,756,652,0004,925,005,0005,309,642,000
Research and development expenses158,000,000183,493,000231,970,000228,624,000
General and administrative expenses02,366,287,0002,388,375,0002,369,494,000
Selling and marketing expenses0776,532,000807,961,000800,876,000
Selling, general and administrative expenses3,033,000,0003,142,819,0003,196,336,0003,170,370,000
Other expenses037,945,000127,261,0000
Operating expenses3,191,000,0003,364,257,0003,555,567,0003,381,934,000
Cost and expenses17,790,000,00017,943,514,00018,084,179,00017,886,262,000
Net interest income-315,000,000-335,469,000-336,423,000-292,476,000
Interest income70,000,00071,575,00086,898,00067,663,000
Interest expense385,000,000407,044,000424,640,000360,000,000
Depreciation and amortization1,500,000,0001,742,257,0001,612,736,0001,838,363,000
EBITDA3,338,000,0003,206,227,0002,933,858,0003,219,997,000
EBIT1,838,000,0001,463,970,0001,321,122,0001,579,418,000
Non-operating income (excl. interest)-69,823,000-71,575,00048,316,00011,893,000
Operating income1,838,000,0001,392,395,0001,369,438,0001,537,946,000
Total other income/expenses (net)-326,000,000-335,469,000-336,423,000-292,476,000
Income before tax1,512,000,0001,056,926,0001,033,015,0001,219,279,000
Income tax expense321,000,000316,056,000300,557,000324,954,000
Net income from continuing operations1,191,000,000740,870,000610,673,000894,325,000
Net income from discontinued operations0000
Other adjustments to net income00121,785,0000
Net income978,000,000537,913,000498,997,000673,405,000
Net income deductions0000
Bottom line net income978,000,000537,913,000498,997,000673,405,000
EPS3222
Diluted EPS3222
Weighted average shares outstanding291,190,575293,413,449293,413,449293,246,430
Weighted average diluted shares outstanding291,193,000293,413,449293,413,449293,246,430

Fresenius Medical Care AG & Co. KGaA Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
8,598,273,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets31,002,000,00033,566,579,00033,929,808,00035,754,000,000
Total liabilities16,719,000,00017,798,066,00019,103,273,00020,305,000,000
Total equity13,309,832,00014,576,563,00013,620,261,00015,449,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents1,599,000,0001,150,947,0001,403,492,0001,273,787,000
Short-term investments127,536,000295,629,000136,286,000169,983,000
Cash and short-term investments1,726,649,0001,446,576,0001,539,778,0001,443,770,000
Net receivables3,142,000,0003,920,868,0004,060,643,0003,719,836,000
Accounts receivable3,142,000,0003,189,720,0003,687,015,0003,694,018,000
Other receivables703,720,000731,148,000360,046,000457,334,000
Inventory2,141,000,0002,067,922,0002,179,175,0002,296,214,000
Prepaid expenses055,356,00045,758,00061,038,000
Other current assets888,351,000432,022,000858,805,000377,811,000
Total current assets7,898,000,0007,922,744,0008,701,411,0008,203,000,000
Property, plant and equipment (net)3,014,000,0007,258,582,0007,454,021,0004,187,000,000
Goodwill13,571,394,00015,170,652,00014,650,008,00015,791,181,000
Intangible assets1,254,489,0001,370,080,0001,362,327,0001,518,677,000
Goodwill and intangible assets14,826,000,00016,540,732,00016,012,335,00017,310,000,000
Long-term investments1,495,213,0001,416,687,0001,254,512,000773,724,000
Tax assets236,547,000229,509,000283,953,000312,679,000
Other non-current assets3,768,787,000198,325,000223,576,0004,967,597,000
Total non-current assets23,104,000,00025,643,835,00025,228,397,00027,551,000,000
Other assets0000
Total assets31,002,000,00033,566,579,00033,929,808,00035,754,000,000
Total payables738,000,0001,268,084,000953,333,000957,187,000
Accounts payable738,000,000984,322,000762,068,000951,584,000
Other payables279,077,000283,762,000191,265,0005,603,000
Accrued expenses0251,980,000250,822,000842,399,000
Short-term debt2,197,332,000577,382,000944,603,0001,363,075,000
Capital lease obligations (current)584,288,000640,884,000616,959,000673,825,000
Tax payables0282,635,000331,861,000267,867,000
Deferred revenue082,165,000336,641,000105,721,000
Other current liabilities3,309,668,0002,839,565,0003,009,232,0002,262,539,000
Total current liabilities6,245,000,0005,660,060,0006,111,590,0006,467,000,000
Long-term debt8,598,273,0006,260,825,0006,959,863,0007,170,734,000
Capital lease obligations (non-current)2,906,421,0003,499,817,0003,528,987,0004,004,938,000
Deferred revenue (non-current)9,760,00034,018,00013,872,0009,474,000
Deferred tax liabilities (non-current)689,523,000708,890,000750,286,000936,475,000
Other non-current liabilities-1,729,556,0001,634,456,0001,738,675,0001,725,474,000
Total non-current liabilities10,474,000,00012,138,006,00012,991,683,00013,838,000,000
Other liabilities0000
Capital lease obligations3,490,709,0004,140,701,0004,145,946,0004,678,763,000
Total liabilities16,719,000,00017,798,066,00019,103,273,00020,305,000,000
Treasury stock-586,094,000000
Preferred stock0000
Common stock293,413,000293,413,000293,413,000293,413,000
Retained earnings12,207,913,00011,266,287,00010,921,686,00010,711,709,000
Additional paid-in capital3,079,368,0003,345,408,0003,380,331,0003,372,799,000
Accumulated other comprehensive income/loss-1,684,768,000-328,545,000-975,169,000-388,468,000
Other stockholders' equity0000
Total stockholders' equity13,309,832,00014,576,563,00013,620,261,00015,449,000,000
Total equity14,283,000,00015,768,513,00014,826,535,00016,908,726,000
Minority interest972,977,0001,191,950,0001,206,274,0001,459,726,000
Total liabilities and total equity31,002,000,00033,566,579,00033,929,808,00035,754,000,000
Total investments1,622,749,0001,712,316,0001,390,798,000943,707,000
Total debt13,702,026,00010,978,908,00012,050,412,00013,212,572,000
Net debt12,103,026,0009,827,961,00010,646,920,00011,938,785,000

Fresenius Medical Care AG & Co. KGaA Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations2,680,999,0002,386,144,0002,628,801,0002,167,379,000
Cash from investing-693,548,000-84,939,000-544,227,000-734,725,000
Cash from financing-1,432,189,000-2,569,300,000-1,858,529,000-1,617,360,000
Net change in cash418,926,000-241,897,000153,438,000-207,868,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income978,367,000740,870,000732,458,000673,405,000
Depreciation and amortization1,463,413,0001,742,257,0001,751,971,0001,838,363,000
Deferred income tax-27,213,000-72,672,000-122,149,000-41,471,000
Stock-based compensation0032,515,000-5,871,000
Change in working capital138,238,000444,313,000561,276,000-128,067,000
Accounts receivable-69,061,000-73,477,000-151,844,000-46,682,000
Inventory-248,658,000107,897,000-13,140,000-204,307,000
Accounts payable-14,766,000155,589,000108,479,000-356,789,000
Other working capital470,723,000254,304,000617,781,00041,778,000
Other non-cash items128,194,000-468,624,000-327,270,000-61,481,000
Net cash from operating activities2,680,999,0002,386,144,0002,628,801,0002,167,379,000
Investments in property, plant and equipment-920,037,000-699,358,000-684,596,000-1,411,000,000
Acquisitions (net)232,515,000606,683,000136,999,00010,526,000
Purchases of investments-89,523,000-81,501,000-108,057,000-128,952,000
Sales/maturities of investments83,497,00075,134,00089,595,00057,671,000
Other investing activities16,695,00014,103,00021,832,00036,205,000
Net cash from investing activities-693,548,000-84,939,000-544,227,000-734,725,000
Net debt issuance798,620,000-1,905,149,000-1,189,793,000-1,118,007,000
Long-term net debt issuance782,968,000-1,449,462,000-1,010,155,000-532,850,000
Short-term net debt issuance15,652,000-455,687,000-249,001,000-585,157,000
Net stock issuance-585,285,0000020,153,000
Net common stock issuance-585,285,000000
Common stock issuance00020,153,000
Common stock repurchased-585,285,00000-20,153,000
Net preferred stock issuance0000
Net dividends paid-422,515,000-349,162,000-328,623,000-395,556,000
Common dividends paid-422,515,000-349,162,000-328,623,000-395,556,000
Preferred dividends paid0000
Other financing activities-1,223,009,000-314,989,000-340,113,000-198,759,000
Net cash from financing activities-1,432,189,000-2,569,300,000-1,858,529,000-1,617,360,000
Effect of FX changes on cash-136,336,00026,198,000-72,607,000-23,162,000
Net change in cash418,926,000-241,897,000153,438,000-207,868,000
Cash at end of period1,599,113,0001,185,328,0001,427,225,0001,273,787,000
Cash at beginning of period1,180,187,0001,427,225,0001,273,787,0001,481,655,000
Operating cash flow2,680,999,0002,386,144,0002,628,801,0002,167,379,000
Capital expenditure-915,369,000-699,358,000-684,596,000-723,988,000
Free cash flow1,765,630,0001,686,786,0001,944,205,0001,443,391,000
Income taxes paid0000
Interest paid0000